Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Salvage HIFU for recurrent prostate cancer after radiotherapy

Prostate Cancer and Prostatic Diseases volume 12, pages 124–129 (2009)Cite this article

Abstract

Recurrent disease following primary radiotherapy for localized prostate cancer is a common problem, occurring in up to 46% of patients. For these patients, therapeutic options include salvage prostatectomy, salvage cryotherapy, salvage high-intensity focused ultrasound (HIFU), hormonal therapy or observation. This review will focus on the emerging evidence for salvage HIFU. There are no randomized or prospective studies in this area. Efficacy results of 17–57% have been reported from retrospective case series, with reported toxicity including rectal fistula in 0–16%, and incontinence in 10–50%. The ideal patient, while yet to be clearly defined, should have preradiotherapy low or intermediate risk disease. Salvage HIFU appears most appropriate for those patients with histologically proven local recurrence only, with a life expectancy of at least 5 years and with some medical comorbidities rendering them not ideal for salvage prostatectomy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Anonymous. Consensus statement: guidelines for PSA following radiation therapy. American society for therapeutic radiology and oncology consensus panel. Int J Radiat Oncol Biol Phys 1997; 37: 1035–1041.

  2. Kuban D, Thames H, Levy L, Horwitz E, Kupelian P, Martinez A et al. Failure definition-dependent differences in outcome following radiation for localized prostate cancer: Can one size fit all? Int J Radiat Oncol Biol Phys 2005; 61: 409–414.

    Article  Google Scholar 

  3. Horwitz EM, Thames HD, Kuban DA, Levy LB, Kupelian PA, Martinez AA et al. Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis. J Urol 2005; 173: 797–802.

    Article  Google Scholar 

  4. Roach III M, Hanks G, Thames Jr H, Schellhammer P, Shipley WU, Sokol GH et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO phoenix consensus conference. Int J Radiat Oncol Biol Phys 2006; 65: 965–974.

    Article  Google Scholar 

  5. Zelefsky MJ, Yamada Y, Fuks Z, Zhang Z, Hunt M, Cahlon O et al. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys 2008; 71: 1028–1033.

    Article  Google Scholar 

  6. Zelefsky MJ, Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 2007; 67: 327–333.

    Article  Google Scholar 

  7. Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR, Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE). Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer 2008; 112: 307–314.

    Article  Google Scholar 

  8. Grossfeld GD, Li YP, Lubeck DP, Broering JM, Mehta SS, Carroll PR . Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor. J Urol 2002; 168: 530–535.

    Article  Google Scholar 

  9. Grossfeld GD, Li YP, P Lubeck DP, Carroll PR . Patterns of failure after primary local therapy for prostate cancer and rationale for secondary therapy. Urology 2002; 60: 57–62; discussion 62–3.

    Article  Google Scholar 

  10. Zelefsky MJ, Reuter VE, Fuks Z, Scardino P, Shippy A . Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer. J Urol 2008; 179: 1368–1373; discussion 1373.

    Article  Google Scholar 

  11. Neerhut GJ, Wheeler T, Cantini M, Scardino PT . Salvage radical prostatectomy for radiorecurrent adenocarcinoma of the prostate. J Urol 1988; 140: 544–549.

    Article  CAS  Google Scholar 

  12. Pisters LL, von Eschenbach AC, Scott SM, Swanson DA, Dinney CP, Pettaway CA et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol 1997; 157: 921–925.

    Article  CAS  Google Scholar 

  13. Rebillard X, Soulie M, Chartier-Kastler E, Davin J, Mignard J, Moreau J et al. High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French association of urology. BJU Int 2008; 101: 1205–1213.

    Article  Google Scholar 

  14. Blana A, Murat FJ, Walter B, Thuroff S, Wieland WF, Chaussy C et al. First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. Eur Urol 2008; 53: 1194–1201.

    Article  Google Scholar 

  15. Sokoloff MH, Steinberg GD, Halabi S, Sanford BL, Eastham JA, Mohler JL et al. Management of recurrent prostate cancer after radiotherapy: results from CALGB 9687, a contemporary prospective multi-institutional salvage radical prostatectomy series. J Urol 2008; 179: 647.

    Article  Google Scholar 

  16. Ng CK, Moussa M, Downey DB, Chin JL . Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome. J Urol 2007; 178: 1253–1257; discussion 1257.

    Article  Google Scholar 

  17. Dudderidge T, Payne H, Emberton M . An algorithm for managing the failure of external beam radiotherapy in prostate cancer. BJU Int 2007; 100: 518–527.

    Article  CAS  Google Scholar 

  18. D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969–974.

    Article  Google Scholar 

  19. Nguyen PL, D’Amico AV, Lee AK, Suh WW . Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer 2007; 110: 1417–1428.

    Article  Google Scholar 

  20. Jarrard DF, Chodak GW . Prostate cancer staging after radiation utilizing laparoscopic pelvic lymphadenectomy. Urology 1995; 46: 538–541.

    Article  CAS  Google Scholar 

  21. Lund GO, Winfield HN, Donovan JF, See WA, Loening SA, Williams RD . Laparoscopic pelvic lymph node dissection following definitive radiotherapy for carcinoma of the prostate. J Urol 1997; 157: 548–551.

    Article  CAS  Google Scholar 

  22. Corvin S, Schilling D, Eichhorn K, Hundt I, Hennenlotter J, Anastasiadis AG et al. Laparoscopic sentinel lymph node dissection--a novel technique for the staging of prostate cancer. Eur Urol 2006; 49: 280–285.

    Article  Google Scholar 

  23. Lawrentschuk N, Davis ID, Bolton DM, Scott AM . Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: current practice. Int J Urol 2007; 14: 89–95.

    Article  CAS  Google Scholar 

  24. Schettino CJ, Kramer EL, Noz ME, Taneja S, Padmanabhan P, Lepor H . Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer. AJR Am J Roentgenol 2004; 183: 519–524.

    Article  Google Scholar 

  25. Chin J, Belhocine T, Baumann G, Moussa M, Stitt L, Driedger A . Added value of SPECT-TC to ProstaScint imaging for biochemical failure following definitive local prostate cancer therapy. Can Urol Assoc J 2008; 2: 251–344.

    Google Scholar 

  26. Lledo Garcia E, Jara Rascon J, Herranz Amo F, Hernandez Fernandez C . Current state of high intensity focused ultrasound (HIFU) as treatment of prostatic carcinoma. Actas Urol Esp 2007; 31: 642–650.

    Article  CAS  Google Scholar 

  27. Poissonnier L, Murat FJ, Chapelon JY, Gelet A . Indications, techniques and outcomes of high-intensity focused ultrasound (HIFU) for the treatment of localized prostate cancer. Ann Urol 2007; 41: 237–253.

    Article  CAS  Google Scholar 

  28. Tsakiris P, Thuroff S, de la Rosette J, Chaussy C . Transrectal high-intensity focused ultrasound devices: a critical appraisal of the available evidence. J Endourol 2008; 22: 221–229.

    Article  Google Scholar 

  29. Murat FJ, Poissonnier L, Pasticier G, Gelet A . High-intensity focused ultrasound (HIFU) for prostate cancer. Cancer Control 2007; 14: 244–249.

    Article  Google Scholar 

  30. Gelet A, Chapelon JY, Poissonnier L, Bouvier R, Rouviere O, Curiel L et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 2004; 63: 625–629.

    Article  Google Scholar 

  31. Blana A, Rogenhofer S, Ganzer R, Wild PJ, Wieland WF, Walter B . Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer. World J Urol 2006; 24: 585–590.

    Article  Google Scholar 

  32. Chapman AT, Rivens IH, Thompson AC, ter Haar GR . High intensity focused ultrasound (HIFU) as a salvage treatment for recurrent prostate cancer after brachytherapy—a feasibility study. AIP Conference Proceedings 2007; 911: 405–410.

    Article  Google Scholar 

  33. Chaussy C, Thueroff S, Kiel HJ . 841 transrectal high intensity focused ultrasound for prostate cancer: impact of the energy dose. Eur Urol Suppl 2004; 3: 213.

    Article  Google Scholar 

  34. Acher PL, Hodgson DJ, Murphy DG, Cahill DJ . High-intensity focused ultrasound for treating prostate cancer. BJU Int 2007; 99: 28–32.

    Article  CAS  Google Scholar 

  35. Ganzer R, Rogenhofer S, Walter B, Lunz JC, Schostak M, Wieland WF et al. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer. Eur Urol 2008; 53: 547–553.

    Article  CAS  Google Scholar 

  36. Uchida T, Illing RO, Cathcart PJ, Emberton M . To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate? BJU Int 2006; 98: 537–539.

    Article  CAS  Google Scholar 

  37. Chaussy C, Thuroff S, Bergsdorf T . Local recurrence of prostate cancer after curative therapy. HIFU (ablatherm) as a treatment option. Urologe A 2006; 45: 1271–1275.

    Article  CAS  Google Scholar 

  38. Murat FJ, Poissonnier L, Rouviere O . Salvage high intensity focused ultrasound (HIFU) treatment for recurrent prostate cancer after radiation therapy: high efficacy in patients with good initial prognosis. 2007. AUA Annual Meeting; Abstract No:1777.

  39. Zacharakis E, Ahmed HU, Ishaq A, Scott R, Illing R, Shaw G et al. MP-08.19: Salvage HIFU effectively reduces PSA in patients with biochemical recurrence after attempted curative treatment for prostate cancer. Urology 2007; 70: 83.

    Google Scholar 

  40. Murat FJ, Poissonnier L, Rouviere O, Pasticier G, Martin X, Chapelon JY et al. Salvage HIFU following a post external beam radiation therapy localized recurrence: a valid and effective treatment option. J Urol 2008; 179: 400.

    Article  Google Scholar 

  41. Seo SI, Jeon SS, Jo MK, Lee HM, Choi HY . Salvage high-intensity focused ultrasound (HIFU) therapy for locally recurrent prostate cancer after primary hifu or external beam radiotherapy (EBRT). Eur Urol Suppl 2008; 7: 119.

    Article  Google Scholar 

  42. Mallick S, Dufour A, Fouques Y, Le Toquin S, Bensadoun H . High-intensity focused ultrasound as a salvage therapy for patients having failed radiation therapy as a primary treatment for prostate cancer. 2007 Prostate Cancer Symposium 2007; Abstract No: 168.

  43. Bianco Jr FJ, Scardino PT, Stephenson AJ, Diblasio CJ, Fearn PA, Eastham JA . Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2005; 62: 448–453.

    Article  Google Scholar 

  44. Ward JF, Sebo TJ, Blute ML, Zincke H . Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol 2005; 173: 1156–1160.

    Article  Google Scholar 

  45. Izawa JI, Madsen LT, Scott SM, Tran JP, McGuire EJ, Von Eschenbach AC et al. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol 2002; 20: 2664–2671.

    Article  Google Scholar 

  46. Lee HK, Adams MT, Motta J . Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy. Brachytherapy 2008; 7: 17–21.

    Article  Google Scholar 

  47. Royce PL, Sothilingam S . Sonablate HIFU therapy for prostate cancer—initial clinical outcomes. BJU Int 2008; 101: 11.

    Google Scholar 

  48. Campbell A . High intensity focused ultrasound (HIFU) for prostate cancer: Single surgeon consecutive series. BJU Int 2008; 101: 14.

    Google Scholar 

  49. Murat FJ, Poissonnier L, Rabilloud M, Belot A, Bouvier R, Rouviere O et al. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur Urol 2008, May 9 [E-pub ahead of print].

  50. Chaussy C, Thueroff S . UP-02.54: Ten years local high intensity focused ultrasound (HIFU) by ablatherm for prostate cancer: profile of side effects. Urology 2006; 68: 268–269.

    Google Scholar 

  51. D’Hont C, Van Erps P, Cortvriend J, Sorber M . High intensity focused ultrasound (HIFU) for PCa: 4 years - 350 patients—ablatherm—AZ Middelheim, Antwerp, Belgium. Urology 2005; 66: 10–11.

    Article  Google Scholar 

  52. D’Hont C, Van Erps P, Cortvriend J, Sorber M, Gelders W . PD-07.10: High intensity focused ultrasound (HIFU) for prostate cancer: outcome 5 years, 450 patients, and sex life, AZ Middelheim, Antwerp, Belgium. Urology 2006; 68: 27.

    Article  Google Scholar 

  53. Andrich DE, Mundy AR . Surgical management of uro-rectal fistula following salvage hifu for recurrent cancer of the prostate after radiotherapy. J Urol 2008; 179: 10.

    Article  Google Scholar 

  54. Kiel HJ, Wieland WF, Rossler W . Local control of prostate cancer by transrectal HIFU-therapy. Arch Ital Urol Androl 2000; 72: 313–319.

    CAS  PubMed  Google Scholar 

  55. Thueroff S, Knauer K, Chaussy C . 10 years high intensity focused ultrasound (HIFU) as local treatment of prostate cancer: profile of side effects. 2006. AUA Annual Meeting; Abstract No: 1133.

  56. Zacharakis E, Ahmed HU, Ishaq A, Scott R, Shaw G, Illing R et al. MP-08.20: Ablative salvage therapy following combination low dose rate brachytherapy and external beam radiation therapy is associated with higher levels of rectal toxicity. Urology 2007; 70: 83.

    Google Scholar 

  57. Stephenson AJ, Scardino PT, Bianco Jr FJ, DiBlasio CJ, Fearn PA, Eastham JA . Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 2004; 172: 2239–2243.

    Article  Google Scholar 

  58. Sanderson KM, Penson DF, Cai J, Groshen S, Stein JP, Lieskovsky G et al. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J Urol 2006; 176: 2025–2031; discussion 2031–2.

    Article  Google Scholar 

  59. van der Poel HG, Beetsma DB, van Boven H, Horenblas S . Perineal salvage prostatectomy for radiation resistant prostate cancer. Eur Urol 2007; 51: 1565–1571; discussion 1572.

    Article  Google Scholar 

  60. Pisters LL, English SF, Scott SM, Westney OL, Dinney CP, McGuire EJ . Salvage prostatectomy with continent catheterizable urinary reconstruction: a novel approach to recurrent prostate cancer after radiation therapy. J Urol 2000; 163: 1771–1774.

    Article  CAS  Google Scholar 

  61. Darras J, Joniau S, Van Poppel H . Salvage radical prostatectomy for radiorecurrent prostate cancer: indications and results. Eur J Surg Oncol 2006; 32: 964–969.

    Article  CAS  Google Scholar 

  62. Dall’Oglio MF, Barreto F, Paranhos M, Nesrallah A, Nesrallah L, Srougi M . Salvage radical prostatectomy: an alternative treatment for local recurrence of radioresistant cancer. Int Braz J Urol 2006; 32: 550–556.

    Article  Google Scholar 

  63. Vaidya A, Soloway MS . Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited. J Urol 2000; 164: 1998–2001.

    Article  CAS  Google Scholar 

  64. Vallancien G, Gupta R, Cathelineau X, Baumert H, Rozet F . Initial results of salvage laparoscopic radical prostatectomy after radiation failure. J Urol 2003; 170: 1838–1840.

    Article  Google Scholar 

  65. Kaouk JH, Hafron J, Goel R, Haber GP, Jones JS . Robotic salvage retropubic prostatectomy after radiation/brachytherapy: initial results. BJU Int 2008; 102: 93–96.

    Article  Google Scholar 

  66. Stolzenburg JU, Bynens B, Do M, Rabenalt R, Katsakiori PF, Liatsikos E . Salvage laparoscopic extraperitoneal radical prostatectomy after failed high-intensity focused ultrasound and radiotherapy for localized prostate cancer. Urology 2007; 70: 956–960.

    Article  Google Scholar 

  67. Ismail M, Ahmed S, Kastner C, Davies J . Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. BJU Int 2007; 100: 760–764.

    Article  Google Scholar 

  68. Han KR, Cohen JK, Miller RJ, Pantuck AJ, Freitas DG, Cuevas CA et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol 2003; 170: 1126–1130.

    Article  Google Scholar 

  69. Murat FJ, Poissonnier L, Colombel M, Martin X, Chapelon JY, Gelet A . Prognostic factors for salvage hifu success after external beam radiation failure. J Urol 2008; 179: 399.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, The University of Western Ontario, London, Ontario, Canada

    V Chalasani, C H Martinez, D Lim & J Chin

Authors
  1. V Chalasani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C H Martinez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Chin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J Chin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chalasani, V., Martinez, C., Lim, D. et al. Salvage HIFU for recurrent prostate cancer after radiotherapy. Prostate Cancer Prostatic Dis 12, 124–129 (2009). https://doi.org/10.1038/pcan.2008.53

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/pcan.2008.53

Keywords

This article is cited by

Search

Advanced search

Quick links